Sweetser Marianne T - Drug Safety, Biogen Idec Inc

基本信息

浏览量：32

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 62 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Helios-a: 9-month results from the randomized treatment extension period of vutrisiran in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy

Laura Obici,Michael Polydefkis,Alejandra Gonzalez-Duarte,Marcia Waddington-Cruz,Yoshiki Sekijima,Julian D. Gillmore,Elena Yureneva,Prajakta Badri,Chongshu Chen,Marianne Sweetser,John Vest,David Adams

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2023): S40-S40

引用0浏览0引用

Résultats Primaires De L’étude APOLLO-B D’extension En Ouvert Du Patisiran Chez Les Patients Atteints D’amylose Cardiaque À Transthyrétine

M.S. Maurer,J.L. Berk,J.D. Gillmore,O. Lairez, M.T. White,M. Sweetser, A.F. Lainé, M. Fontana

La Revue de Médecine Interne (2023): A372

引用0浏览0引用

Efficacité Et Sécurité D’emploi Du Givosiran Chez Des Patients Atteints De Porphyrie Hépatique Aiguë : Résultats À 36 Mois De L’essai Clinique Randomisé De Phase 3 ENVISION

M. Thapar, H. Bonkovsky, S. Monroy, G. Ross,E. Guillén-Navarro, M.D. Cappellini, A.E. Minder, S. Liu,M. Sweetser, A.F. Lainé, L. Poizat,D. Kuter

La Revue de médecine interne (2022): A479-A480

引用0浏览0引用

Long-term Safety and Efficacy of Patisiran in Patients with hATTR Amyloidosis: Global OLE Study

Michael Polydefkis,Alejandra Gonzalez-Duarte,Teresa Coelho,Jonas Wixner,Arnt Kristen,Hartmut Schmidt,John L. Berk,Erhan Berber,Marianne Sweetser,Matthew White,Jing Jing Wang,David Adams

NEUROLOGY（2020）

引用0浏览0引用

Long-term Integrated Safety of Patisiran in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy

Angela Dispenzieri,Julian Gillmore,Michael Polydefkis,Violaine Plante-Bordeneuve,Hartmut Schmidt,Erhan Berber, Jing,Marianne Sweetser,Matthew White,Mathew Maurer

European Heart Journal（2020）

引用1浏览0引用

Long-term Safety and Efficacy of Patisiran in Patients with Hattr Amyloidosis : Global OLE Study

M. Polydefkis,A. González-Duarte, T. Coelho, J. Wixner, A. Kristen, H. Schmidt, J. Berk, E. Berber,M. Sweetser, M. White, Jing, D. Adams

semanticscholar（2020）

引用0浏览0引用

P.025 APOLLO, a Phase 3 Study of Patisiran for the Treatment of Hereditary Transthyretin Amyloidosis (hattr): 18-Month Safety and Efficacy in Subgroup with Cardiac Involvement

J Vest, S Solomon, D Adams,A Gonzalez-Duarte,W O’Riordan,C Yang,T Coelho,J Berk,K Lin,P Dyck, PJ Gandhi,M Sweetser,OB Suhr,A Kristen

Canadian journal of neurological sciences（2019）

引用0浏览0引用

P.024 Long-term use of patisiran in patients with hereditary transthyretin amyloidosis (hATTR): 12 month efficacy & safety data from a global open label extension (OLE) study

A Gonzalez-Duarte,T Coelho,D Adams,C Yang,M Polydefkis,A Kristen,I Tournev,H Schmidt,J Berk,K Lin, PJ Gandhi,M Sweetser, M White,J Gollob,OB Suhr, Apollo Study Investigators

Canadian Journal of Neurological Sciences（2019）

引用0浏览0引用

Outcomes of Patients with Hereditary Transthyretin-Mediated Amyloidosis with Early Onset V30M Versus All Other Mutations in APOLLO, a Phase 3 Study of Patisiran

T. Coelho,D. Adams,A. Gonzalez-Duarte,W. O'riordan, C. -C. Yang,T. Yamashita,A. Kristen,I. Tournev,H. Schmidt,J. Berk,K. -P. Lin,P. Gandhi,M. Sweetser, M. White,S. Goyal,J. Gollob,O. Suhr

Revue neurologique（2019）

引用2浏览0引用

Impact of Patisiran on Norfolk Quality of Life Questionnaire Diabetic Neuropathy (QOL-DN) in patients with Hereditary transthyretin-mediated Amyloidosis: results from the Phase-3 APOLLO study

L. Obici,T. Coelho, D. Adams,A. Gonzalez-Duarte, W. O'riordan, C. -C. Yang,T. Yamashita,A. Kristen,I. Tournev,H. Schmidt,J. Berk,K. -P. Lin,P. Gandhi,M. Sweetser, J. Chen,S. Goyal,J. Gollob,O. Suhr

EUROPEAN JOURNAL OF NEUROLOGY（2018）

引用3浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn